GGrantIndex
← Leaderboards

Marjana Tomic-Canic

University Of Miami School Of Medicine

$10,626,647
Attributed
$17,704,039
Total exposure
14
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,704,039 · 14

By mechanism

R01$12,670,191 · 7
U01$1,753,298 · 1
RC1$902,641 · 1
R61$821,177 · 1
R21$773,300 · 2
R33$759,432 · 1

Top collaborators

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Healing

Research focus

HealingResponseTissuesSkinWound HealingDiabetic Foot UlcerWoundBaseCellsChronicCaringCostAffectMolecularNovel Therapeutic InterventionMortalityFutureMorbidity - Disease RateGene ExpressionComplications Of Diabetes MellitusImpaired Wound HealingAmputationUlcerInfection

Grant awards (48)

Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis$611,834
R01 · FY2025 · DK · contact PI
The role of cortisol synthesis in pathogenesis of Hidradenitis suppurativa tunnels$419,579
R01 · FY2025 · AR · contact PI
Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers$379,716
R33 · FY2025 · DK
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis$600,830
R01 · FY2024 · DK · contact PI
The role of cortisol synthesis in pathogenesis of Hidradenitis suppurativa tunnels$466,198
R01 · FY2024 · AR · contact PI
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis$410,368
R01 · FY2024 · DK · contact PI
Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers$379,716
R33 · FY2024 · DK
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis$608,245
R01 · FY2023 · DK · contact PI
Developing strategies for effective debridement in patients for venous leg ulcers$472,517
R01 · FY2023 · AR · contact PI
Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers$398,806
R61 · FY2023 · DK
2023 Barrier Function of Mammalian Skin Gordon Research Conferences and Gordon Research Seminar$24,000
R13 · FY2023 · AR · contact PI
Developing strategies for effective debridement in patients for venous leg ulcers$534,702
R01 · FY2022 · AR · contact PI
Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers$422,371
R61 · FY2022 · DK
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$1
U01 · FY2022 · DK
Developing strategies for effective debridement in patients for venous leg ulcers$523,900
R01 · FY2021 · AR · contact PI
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$611,374
U01 · FY2020 · DK
Developing strategies for effective debridement in patients for venous leg ulcers$530,649
R01 · FY2020 · AR · contact PI
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$109,226
U01 · FY2020 · DK
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers$507,981
R01 · FY2019 · NR · contact PI
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$421,323
U01 · FY2019 · DK
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$190,051
U01 · FY2019 · DK
Developing strategies for effective debridement in patients for venous leg ulcers$565,514
R01 · FY2018 · AR · contact PI
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers$515,514
R01 · FY2018 · NR · contact PI
University of Miami Clinical Research Unit of the Diabetic Foot Consortium$421,323
U01 · FY2018 · DK
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers$522,907
R01 · FY2017 · NR · contact PI
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers$530,148
R01 · FY2016 · NR · contact PI
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers$537,250
R01 · FY2015 · NR · contact PI
Micro-RNA Molecules as Regulators of Diabetic Wound Healing$399,942
R01 · FY2015 · NR · contact PI
Micro-RNA Molecules as Regulators of Diabetic Wound Healing$419,462
R01 · FY2014 · NR · contact PI
Micro-RNA Molecules as Regulators of Diabetic Wound Healing$415,184
R01 · FY2013 · NR · contact PI
Micro-RNA Molecules as Regulators of Diabetic Wound Healing$446,067
R01 · FY2012 · NR · contact PI
The Role of Statins in Cutaneous Wound Healing$206,550
R21 · FY2012 · AR · contact PI
The Role of Statins in Cutaneous Wound Healing$172,125
R21 · FY2011 · AR · contact PI
Development of the Cellular Biomarker for Diabetic Foot Ulcers$444,111
RC1 · FY2010 · DK · contact PI
Development of the Cellular Biomarker for Diabetic Foot Ulcers$458,530
RC1 · FY2009 · DK · contact PI
Experimental Model For Pressure Ulcers In Human Skin: The Role of Aging and ECM$215,250
R21 · FY2009 · AG · contact PI
Experimental Model For Pressure Ulcers In Human Skin: The Role of Aging and ECM$179,375
R21 · FY2008 · AG · contact PI
Epidermal Genes and Their Regulators in Wound Healing$326,412
R01 · FY2007 · NR · contact PI
Epidermal Genes and Their Regulators in Wound Healing$336,160
R01 · FY2006 · NR · contact PI
Epidermal Genes and Their Regulators in Wound Healing$244,414
R01 · FY2005 · NR
Epidermal Genes and Their Regulators in Wound Healing$99,248
R01 · FY2005 · NR
Epidermal Genes and Their Regulators in Wound Healing$339,120
R01 · FY2004 · NR
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTION$201,724
R01 · FY2004 · AR
Epidermal Genes and Their Regulators in Wound Healing$326,430
R01 · FY2003 · NR
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTION$195,850
R01 · FY2003 · AR
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTION$190,534
R01 · FY2002 · AR
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTION$185,357
R01 · FY2001 · AR
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTION$186,151
R01 · FY2000 · AR